Wespac Advisors So Cal, LLC Novartis Ag Transaction History

Wespac Advisors So Cal, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$75.4 - $92.8 $133,835 - $164,720	-1,775 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$66.94 - $77.43 $118,818 - $137,438	1,775 New	1,775 $152,000
Q2 2018 Jul 13, 2018	SELL	$64.91 - $73.36 $118,460 - $133,882	-1,825 Closed	0 $0
Q3 2017 Nov 03, 2017	SELL	$74.14 - $77.27 $1,853 - $1,931	-25 Reduced 1.35%	1,825 $156,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,850	1,850 $154,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.